Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study (Q46121510)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 June 2017

Language	Label	Description	Also known as
English	Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study	scientific article published on 8 June 2017

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/28596446

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/28596446

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

5

object named as

Felix Hilpert

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Felicia T Roncolato

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Rachel O'Connell

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Luke Buizen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Aikou Okamoto

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Eriko Aotani

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sandro Pignata

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Paul Donnellan

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Amit Oza

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Elisabeth Avall-Lundqvist

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jonathan S Berek

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Amanda Feeney

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Dominique Berton-Rigaud

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Martin R Stockler

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Madeleine King

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Michael Friedlander

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

GCIG Symptom Benefit group

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

8 June 2017

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/28596446

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1117-1124

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28596446%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

"Platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Health-related quality of life and cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

The prognostic significance of patient-reported outcomes in cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Optimal chemotherapy treatment for women with recurrent ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Ovarian cancer: a focus on management of recurrent disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

The role of C-reactive protein as a prognostic indicator in advanced cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

A prognostic model for ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Health-related quality-of-life assessment in clinical trials of supportive care in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Second-line treatment of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Factors predictive of survival after first relapse or progression in advanced epithelial ovarian carcinoma: a prediction tree analysis-derived model with test and validation groups.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5599194

29 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic role of pre-chemotherapy hemoglobin level in patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [seecomments]

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Challenge of Prognostic Uncertainty in the Modern Era of Cancer Therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/28596446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1634/THEONCOLOGIST.2017-0047

1 reference

https://api.fatcat.wiki/v0/release/wv7g4ea24rdzfkltff3fadiz4a

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_wv7g4ea24rdzfkltff3fadiz4a

1 reference

https://api.fatcat.wiki/v0/release/wv7g4ea24rdzfkltff3fadiz4a

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/wv7g4ea24rdzfkltff3fadiz4a

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/wv7g4ea24rdzfkltff3fadiz4a

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46121510&oldid=2093434919"